Table 2

Serum analyte characteristics of colorectal cancer cases and matched controls by fasting status

	Not fasting			In between			Fasting			p Value^‡
	Cases	Controls	p Value^†	Cases	Controls	p Value^†	Cases	Controls	p Value^†	p Value^‡
Total number of subjects	599	604		287	284		329	329
Serum analytes^*
Total cholesterol (mg/dl)	247.5 (216.2 to 280.7)	250.6 (222.0 to 283.5)	0.14	247.5 (220.8 to 279.2)	251.4 (226.6 to 284.6)	0.47	234.7 (206.5 to 266.4)	240.5 (211.9 to 269.9)	0.18	<0.01
HDL- cholesterol (mg/dl)	54.5 (44.5 to 65.7)	55.3 (45.6 to 68.4)	0.07	54.1 (44.5 to 67.7)	53.8 (45.2 to 67.3)	0.96	52.6 (42.2 to 63.4)	54.1 (45.6 to 63.8)	0.03	0.57
LDL- cholesterol (mg/dl)	162.4 (133.8 to 189.1)	161.6 (136.1 to 194.1)	0.40	163.6 (137.3 to 191.0)	164.7 (143.2 to 190.6)	0.50	161.3 (137.7 to 188.3)	167.0 (139.6 to 193.4)	0.14	0.58
Triglycerides (mg/dl)	146.1 (100.1 to 211.7)	140.8 (96.5 to 200.2)	0.12	138.2 (94.8 to 201.9)	138.2 (99.2 to 192.2)	0.98	98.3 (67.0 to 139.9)	94.8 (70.0 to 135.5)	0.45	<0.01
Apolipoprotein A-1 (mg/dl)	172.0 (151.0 to 193.0)	174.0 (155.0 to 194.0)	0.23	173.0 (152.0 to 201.0)	174.0 (150.0 to 198.0)	0.52	167.0 (147.0 to 187.0)	170.0 (150.0 to 189.0)	0.10	0.18
Apolipoprotein B (mg/dl)	120.0 (101.0 to 139.0)	119.0 (101.0 to 138.0)	0.59	120.0 (104.0 to 137.0)	121.0 (105.0 to 139.0)	0.65	117.0 (102.0 to 133.0)	118.0 (102.0 to 133.0)	0.64	0.23

↵* Values are median (IQR).
↵† p Value for difference between cases and controls per fasting status category calculated using the Wilcoxon two-sample test.
↵‡ p Value for difference between controls over fasting status categories calculated using the Kruskal–Wallis test.